Mahmoud H. Zahran - Publications

In vivo investigation of the anti-liver fibrosis impact of Balanites aegyptiaca/ chitosan nanoparticles.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 06, 2023

Autophagy modulators in type 2 diabetes: A new perspective.

Journal: Journal of diabetes

Published: July 13, 2023

Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night.

Journal: CNS neuroscience & therapeutics

Published: July 13, 2023

Impact of intravenous/intranasal polyinosinic-polycytidylic acid administration on the mediastinal fat-associated lymphoid clusters and lung tissue in healthy mice.

Journal: Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft

Published: March 06, 2023

Microenvironmental Changes in Mediastinal Fat-associated Lymphoid Clusters and Lungs in Early and Late Stages of Metastatic Lung Cancer Induction.

Journal: Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada

Published: January 22, 2023

Parkinson's Disease Risk and Hyperhomocysteinemia: The Possible Link.

Journal: Cellular and molecular neurobiology

Published: January 07, 2023

Barhi date (Phoenix dactylifera) extract ameliorates hepatocellular carcinoma in male rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 05, 2022

Parathormone enhances eryptosis in patients with end stage renal disease treated by hemodialysis.

Journal: Hemodialysis international. International Symposium on Home Hemodialysis

Published: May 14, 2021

Hepatitis C-related membranoproliferative glomerulonephritis in the era of direct antiviral agents.

Journal: Jornal brasileiro de nefrologia

Published: July 01, 2020

Real-world safety and effectiveness of retreatment of Egyptian chronic hepatitis C patients not responding to NS5A inhibitor-based therapies.

Journal: Journal of viral hepatitis

Published: March 25, 2020

Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents.

Journal: Le infezioni in medicina

Published: September 25, 2018